Header Logo

Connection

Clement Penny to Antineoplastic Agents

This is a "connection" page, showing publications Clement Penny has written about Antineoplastic Agents.
Connection Strength

0,380
  1. A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer. Br J Pharmacol. 2024 01; 181(1):107-124.
    View in: PubMed
    Score: 0,219
  2. Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. Expert Opin Drug Deliv. 2011 Oct; 8(10):1323-40.
    View in: PubMed
    Score: 0,094
  3. Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting. Int J Mol Sci. 2018 Oct 04; 19(10).
    View in: PubMed
    Score: 0,039
  4. Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine. 2014; 9:589-613.
    View in: PubMed
    Score: 0,028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.